DekaBank Deutsche Girozentrale Raises Stock Position in Waters Co. (NYSE:WAT)


Share on StockTwits

DekaBank Deutsche Girozentrale lifted its stake in shares of Waters Co. (NYSE:WAT) by 10.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 99,805 shares of the medical instruments supplier’s stock after acquiring an additional 9,280 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Waters were worth $24,555,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Cetera Advisor Networks LLC increased its holdings in shares of Waters by 1.9% in the 4th quarter. Cetera Advisor Networks LLC now owns 2,311 shares of the medical instruments supplier’s stock valued at $572,000 after acquiring an additional 43 shares during the period. Savant Capital LLC increased its holdings in shares of Waters by 3.8% in the 4th quarter. Savant Capital LLC now owns 1,239 shares of the medical instruments supplier’s stock valued at $307,000 after acquiring an additional 45 shares during the period. CWM Advisors LLC increased its holdings in shares of Waters by 1.3% in the 4th quarter. CWM Advisors LLC now owns 4,223 shares of the medical instruments supplier’s stock valued at $1,045,000 after acquiring an additional 53 shares during the period. Meeder Asset Management Inc. increased its holdings in shares of Waters by 6.5% in the 4th quarter. Meeder Asset Management Inc. now owns 1,182 shares of the medical instruments supplier’s stock valued at $292,000 after acquiring an additional 72 shares during the period. Finally, Treasurer of the State of North Carolina increased its holdings in shares of Waters by 0.3% in the 4th quarter. Treasurer of the State of North Carolina now owns 23,465 shares of the medical instruments supplier’s stock valued at $5,806,000 after acquiring an additional 80 shares during the period. Institutional investors and hedge funds own 91.80% of the company’s stock.

In related news, Director Joann A. Reed sold 1,600 shares of the business’s stock in a transaction dated Friday, March 5th. The shares were sold at an average price of $263.31, for a total value of $421,296.00. Also, Director Joann A. Reed sold 4,759 shares of the business’s stock in a transaction dated Tuesday, February 9th. The stock was sold at an average price of $282.39, for a total transaction of $1,343,894.01. Following the completion of the sale, the director now owns 36,683 shares in the company, valued at $10,358,912.37. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.

NYSE:WAT opened at $296.35 on Thursday. Waters Co. has a fifty-two week low of $171.38 and a fifty-two week high of $304.49. The stock has a market cap of $18.43 billion, a PE ratio of 36.91, a price-to-earnings-growth ratio of 8.79 and a beta of 0.97. The firm’s fifty day simple moving average is $275.95 and its 200-day simple moving average is $247.40.

Waters (NYSE:WAT) last posted its quarterly earnings results on Monday, February 1st. The medical instruments supplier reported $3.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.89 by $0.76. Waters had a net margin of 22.61% and a negative return on equity of 349.31%. The business had revenue of $786.66 million for the quarter, compared to analysts’ expectations of $711.10 million. During the same period in the prior year, the company posted $3.20 EPS. On average, analysts forecast that Waters Co. will post 7.94 EPS for the current year.

A number of brokerages have recently commented on WAT. TheStreet raised shares of Waters from a “c” rating to an “a-” rating in a report on Tuesday, February 2nd. Smith Barney Citigroup raised shares of Waters from a “sell” rating to a “neutral” rating in a research note on Wednesday, December 16th. Wells Fargo & Company cut shares of Waters from an “equal weight” rating to an “underweight” rating and set a $235.00 price objective on the stock. in a research note on Thursday, January 7th. Cleveland Research raised shares of Waters from an “underperform” rating to a “buy” rating in a research note on Thursday, December 17th. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised shares of Waters from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $185.00 to $240.00 in a research note on Wednesday, December 16th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. Waters has an average rating of “Hold” and a consensus target price of $225.27.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Article: Pattern Day Trader

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.